Skip to main content
Home

Main navigation

  • Home
  • News
  • About HIV
  • About us
  • Subscribe to news
Search
Donate now

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you.

I am a UK taxpayer and I understand that if I pay less Income and /or Capital Gains Tax than the amount of Gift Aid claimed on all my donations in the relevant tax year, it is my responsibility to pay any difference.

In our 35th year we’re asking people to donate £35 – that’s just £1 for every year we’ve been providing life-changing information. Any donation you make helps us continue our work towards a world where HIV is no longer a threat to health or happiness.

  • £5 allows us to reach millions of people globally with accurate and reliable resources about HIV prevention and treatment.
  • £10 helps us produce news and bulletins on the latest developments in HIV for healthcare staff around the world.
  • £35 means we can empower more people living with HIV to challenge stigma with our information workshops, videos and broadcasts.

Showing 57 results

Filters Content type: News, Editors' picks Topic: Antibody-based treatment
New & experimental HIV treatments

Ibalizumab monoclonal antibody looks promising for people with drug-resistant HIV

News
4 November 2016
New & experimental HIV treatments

PRO 140 antibody injections maintain viral suppression in phase 2 study

News
28 June 2016
The search for a cure

VRC01 antibody delays but does not prevent HIV rebound after antiretroviral treatment interruption

News
8 April 2016
New & experimental HIV treatments

Dose-finding trials of antibody-based drugs for HIV prevention will start soon

News
24 February 2016
New & experimental HIV treatments

New way of attacking HIV looks promising in early trial

News
25 March 2008
New & experimental HIV treatments

ICAAC: Phase 1 study provides `proof of concept` for PRO 140, a monoclonal CCR5 antibody

News
21 September 2007
New & experimental HIV treatments

Substantial HIV reduction persists for 2-3 weeks with single dose of PRO-140 antibody

News
1 May 2007
New & experimental HIV treatments

Antibody to CCR5 receptor safe, effective, suitable for weekly dosing, preliminary study shows

News
30 September 2006
New & experimental HIV treatments

Novel antibody enters trials as HIV treatment

News
13 June 2003

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Current page 3

Refine search

By content type
From
To
Topic

About us

Our information is intended to support, rather than replace, consultation with a healthcare professional.

Talk to your doctor or another member of your healthcare team for advice tailored to your situation.

Connect with us

  • Twitter
  • Bluesky
  • Facebook
  • YouTube
  • Instagram

Links

Show — Links Hide — Links
  • Contact us
  • THT Direct Helpline
  • Subscribe to email bulletins

 

aidsmap (previously known as NAM aidsmap) is now hosted by Terrence Higgins Trust, an HIV charity based in the United Kingdom.

 

Copyright 2026 © Terrence Higgins Trust is a registered charity in England and Wales (reg. no. 288527) Company reg. no. 1778149 and a registered charity in Scotland (reg. no. SC039986). Registered office: 437 & 439 Caledonian Road, London, N7 9BG.

Footer menu

Show — Footer menu Hide — Footer menu
  • Accessibility
  • Compliment, complaint or concern
  • Our information
  • Privacy & cookies
  • Terms of use
  • Terrence Higgins Trust